Atsushi Sengoku
Overview
Explore the profile of Atsushi Sengoku including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mukai S, Nomi M, Yanagiuchi A, Sengoku A
Low Urin Tract Symptoms
. 2024 Dec;
17(1):e70001.
PMID: 39632546
Objectives: The objective of this study is to compare the 3-year continuation rate and discontinuation factors between vibegron and mirabegron in patients with overactive bladder in a rehabilitation hospital in...
2.
Sekido N, Matsuyama F, Murata T, Takahashi R, Matsuoka M, Sengoku A, et al.
Sci Rep
. 2024 Oct;
14(1):24383.
PMID: 39420068
While preventing renal damage and symptomatic urinary tract infection are of paramount importance to persons with a spinal cord lesion (SCL), patient-reported outcomes (PROs) are receiving much more attention than...
3.
Sekido N, Takahashi R, Matsuyama F, Tatsunori M, Matsuoka M, Sengoku A, et al.
Low Urin Tract Symptoms
. 2024 May;
16(3):e12515.
PMID: 38693055
Objectives: To investigate factors associated with symptomatic urinary tract infection (sUTI) in persons with chronic spinal cord lesion (SCL) who were using single-use catheters for intermittent self-catheterization (ISC). Methods: Among...
4.
Sekido N, Kitta T, Sengoku A, Takahashi R, Nomi M, Matsuoka M, et al.
Nihon Hinyokika Gakkai Zasshi
. 2024 Apr;
114(2):35-52.
PMID: 38644185
(Objectives) To develop Japanese translations of the standard and short forms of the Neurogenic Bladder Symptom Score (Subjects and methods) The questionnaires were forward translated by a Japanese healthcare professional...
5.
Takahashi R, Sekido N, Matsuoka M, Sengoku A, Nomi M, Matsuyama F, et al.
Low Urin Tract Symptoms
. 2023 Jun;
15(5):165-172.
PMID: 37300392
Objectives: To investigate hygiene management and catheter maintenance of reusable silicone catheters for intermittent self-catheterization (ISC) in Japan and examine their relationship with symptomatic urinary tract infection (sUTI). Methods: We...
6.
Sekido N, Matsuoka M, Takahashi R, Sengoku A, Nomi M, Matsuyama F, et al.
Spinal Cord Ser Cases
. 2023 Feb;
9(1):3.
PMID: 36781838
Study Design: Cross-sectional study by members of patient advocacy groups. Objectives: To evaluate the incidence and frequency of symptomatic urinary tract infection (sUTI) in persons with spinal cord lesion (SCL)...
7.
Mukai S, Nomi M, Kozawa S, Yanagiuchi A, Shigemura K, Sengoku A
Neurourol Urodyn
. 2022 Jun;
41(6):1440-1450.
PMID: 35673967
Aims: To investigate the changes in the proportion of antimicrobial prophylaxis (AP) during the urodynamic study (UDS) and the frequency of posttest genito-urinary tract infections (GUTI) before and after coronavirus...
8.
Takami N, Mukai S, Nomi M, Yanagiuchi A, Sengoku A, Maeda K, et al.
Urol Int
. 2022 Jan;
106(7):722-729.
PMID: 35066505
Introduction: We retrospectively investigated the risk factors for post-urodynamic study (UDS) infectious complications in long-term hospitalized inpatients with suspected neurogenic lower urinary tract disturbance (NLUTD) in a monocenter study, to...
9.
Mukai S, Shigemura K, Yang Y, Nomi M, Yanagiuchi A, Fang S, et al.
Am J Infect Control
. 2021 Nov;
50(6):668-672.
PMID: 34736991
Background: Antimicrobial prescriptions are relatively common in urologic outpatients. Therefore, it is necessary to investigate the impact of antimicrobial stewardship program (ASP) interventions. Methods: In urology outpatients, antimicrobial use density...
10.
Mukai S, Nomi M, Yamada S, Yanagiuchi A, Sengoku A
Low Urin Tract Symptoms
. 2021 May;
13(4):448-455.
PMID: 34032007
Objectives: To compare the 1-year continuation rate and discontinuation factors between vibegron and mirabegron in patients with neurogenic and nonneurogenic overactive bladder. Methods: Continuation or discontinuation of the target drugs...